Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1984 May;52(1):181–188.

Immunolocalization of complement component C9 on necrotic and non-necrotic muscle fibres in myositis using monoclonal antibodies: a primary role of complement in autoimmune cell damage.

B P Morgan, C A Sewry, K Siddle, J P Luzio, A K Campbell
PMCID: PMC1454595  PMID: 6370840

Abstract

Monoclonal antibodies to human complement component C9 were used to localise the membrane attack complex (MAC) of human complement on muscle fibres from patients with autoimmune myositis. A pigeon erythrocyte 'model' system was used to screen the available monoclonal antibodies for their ability to bind C9 after its insertion into the MAC. Three of the five antibodies tested were demonstrated, using radioiodine- or rhodamine-labelled second antibody, to bind. The antibody giving maximum binding in this system was used to demonstrate that MACs were present on histologically normal as well as on necrotic fibres in myositis. No binding was seen in muscle from control subjects. These results suggest a primary role of complement in the pathogenesis of muscle fibre necrosis in myositis.

Full text

PDF
181

Images in this article

184Figure 1
on p.184
185Figure 2
on p.185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azanza J. L., Raymond J., Robin J. M., Cottin P., Ducastaing A. Purification and some physico-chemical and enzymic properties of a calcium ion-activated neutral proteinase from rabbit skeletal muscle. Biochem J. 1979 Nov 1;183(2):339–347. doi: 10.1042/bj1830339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Biesecker G., Katz S., Koffler D. Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis. J Exp Med. 1981 Dec 1;154(6):1779–1794. doi: 10.1084/jem.154.6.1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bodensteiner J. B., Engel A. G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology. 1978 May;28(5):439–446. doi: 10.1212/wnl.28.5.439. [DOI] [PubMed] [Google Scholar]
  4. Bottazzo G. F., Dean B. M., Gorsuch A. N., Cudworth A. G., Doniach D. Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet. 1980 Mar 29;1(8170):668–672. [PubMed] [Google Scholar]
  5. Boyle M. D., Borsos T. The terminal stages of immune hemolysis--a brief review. Mol Immunol. 1980 Mar;17(3):425–432. doi: 10.1016/0161-5890(80)90064-4. [DOI] [PubMed] [Google Scholar]
  6. Burakoff S. J., Martz E., Benacerraf B. Is the primary complement lesion insufficient for lysis? Failure of cells damaged under osmotic protection to lyse in EDTA or at low temperature after removal of osmotic protection. Clin Immunol Immunopathol. 1975 May;4(1):108–126. doi: 10.1016/0090-1229(75)90045-8. [DOI] [PubMed] [Google Scholar]
  7. Busch W. A., Stromer M. H., Goll D. E., Suzuki A. Ca 2+ -specific removal of Z lines from rabbit skeletal muscle. J Cell Biol. 1972 Feb;52(2):367–381. doi: 10.1083/jcb.52.2.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Campbell A. K., Daw R. A., Luzio J. P. Rapid increase in intracellular free Ca2+ induced by antibody plus complement. FEBS Lett. 1979 Nov 1;107(1):55–60. doi: 10.1016/0014-5793(79)80462-7. [DOI] [PubMed] [Google Scholar]
  9. Campbell A. K., Luzio J. P. Intracellular free calcium as a pathogen in cell damage initiated by the immune system. Experientia. 1981 Oct 15;37(10):1110–1112. doi: 10.1007/BF02085041. [DOI] [PubMed] [Google Scholar]
  10. Carpenter S., Karpati G. Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain. 1979 Mar;102(1):147–161. doi: 10.1093/brain/102.1.147. [DOI] [PubMed] [Google Scholar]
  11. Edwards R. H., Lewis P. D., Maunder C., Pearse A. G. Percutaneous needle biopsy in the diagnosis of muscle diseases. Lancet. 1973 Nov 10;2(7837):1070–1071. doi: 10.1016/s0140-6736(73)92672-x. [DOI] [PubMed] [Google Scholar]
  12. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  13. Hammer C. H., Shin M. L., Abramovitz A. S., Mayer M. M. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes. J Immunol. 1977 Jul;119(1):1–8. [PubMed] [Google Scholar]
  14. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  15. Mokri B., Engel A. G. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology. 1975 Dec;25(12):1111–1120. doi: 10.1212/wnl.25.12.1111. [DOI] [PubMed] [Google Scholar]
  16. Oberc M. A., Engel W. K. Ultrastructural localization of calcium in normal and abnormal skeletal muscle. Lab Invest. 1977 Jun;36(6):566–577. [PubMed] [Google Scholar]
  17. ROITT I. M., DONIACH D., CAMPBELL P. N., HUDSON R. V. Auto-antibodies in Hashimoto's disease (lymphadenoid goitre). Lancet. 1956 Oct 20;271(6947):820–821. doi: 10.1016/s0140-6736(56)92249-8. [DOI] [PubMed] [Google Scholar]
  18. Ramm L. E., Whitlow M. B., Koski C. L., Shin M. L., Mayer M. M. Elimination of complement channels from the plasma membranes of U937, a nucleated mammalian cell line: temperature dependence of the elimination rate. J Immunol. 1983 Sep;131(3):1411–1415. [PubMed] [Google Scholar]
  19. Rauterberg E. W., Ungemach B., Gebest H. J. Quantitative measurement of C9 sites and their association to the ring-like "lesions" on complementlysed membranes: a morphometric immunoferritin study. J Immunol. 1979 Jan;122(1):355–365. [PubMed] [Google Scholar]
  20. Richardson P. J., Luzio J. P. Complement-mediated production of plasma-membrane vesicles from rat fat-cells. Biochem J. 1980 Mar 15;186(3):897–906. doi: 10.1042/bj1860897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rommel F. A., Mayer M. M. Studies of guinea pig complement component C9: reaction kinetics and evidence that lysis of EAC1-8 results from a single membrane lesion caused by one molecule of C9. J Immunol. 1973 Mar;110(3):637–647. [PubMed] [Google Scholar]
  22. Sahashi K., Engel A. G., Lambert E. H., Howard F. M., Jr Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. J Neuropathol Exp Neurol. 1980 Mar;39(2):160–172. doi: 10.1097/00005072-198003000-00005. [DOI] [PubMed] [Google Scholar]
  23. Schlager S. I., Ohanian S. H., Borsos T. Stimulation of the synthesis and release of lipids in tumor cells under attack by antibody and C. J Immunol. 1978 Mar;120(3):895–901. [PubMed] [Google Scholar]
  24. Schliwa M. The role of divalent cations in the regulation of microtubule assembly. In vivo studies on microtubules of the heliozoan axopodium using the ionophore A23187. J Cell Biol. 1976 Sep;70(3):527–540. doi: 10.1083/jcb.70.3.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schmalbruch H. Segmental fibre breakdown and defects of the plasmalemma in diseased human muscles. Acta Neuropathol. 1975 Dec 8;33(2):129–141. doi: 10.1007/BF00687539. [DOI] [PubMed] [Google Scholar]
  26. Wrogemann K., Blanchaer M. C., Jacobson B. E. A calcium-associated magnesium-responsive defect of respiration and oxidative phosphorylation by skeletal muscle mitochondria of BIO 14.6 dystrophic hamsters. Life Sci II. 1970 Oct 22;9(20):1167–1173. doi: 10.1016/0024-3205(70)90035-4. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES